(Crain’s) — Abbott Laboratories sued Johnson & Johnson to stop it from rolling out a rheumatoid arthritis medication that would compete with Abbott’s top-selling drug, Humira. In a lawsuit filed in ...
Abbott initiated two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA (adalimumab) in adult patients with moderate to severe hidradenitis ...
(AP) — Abbott Laboratories says it beat its own expectations in the third quarter as sales of its drug Humira continued to climb, as did sales of medical products and nutritional products for children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback